Steffen Ormanns

Die stille Krise der Pathologie INTERVIEW | Für ihre Diagnose haben Pathologen oft nur einen Versuch: „Fehler, Zeitdruck oder Unterfinanzierung lassen sich hier nicht korrigieren“, mahnt der Vorsitzende der Deutschen Gesellschaft fü...

Interessantes und informatives Interview mit Prof. Christoph Röcken, Pathologie des UKSH Kiel zum derzeitigen Stand unseres Faches.
www.doccheck.com/de/detail/ar...

Why don't these media outlets never quote the original study? Makes it much harder to verify the scientific context...

Yes so much research showing so much promise 💜

Erst hat man kein Geld, dann keine Zeit, dann ist man tot.
Johannes Franzen

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance | PNAS Pancreatic ductal adenocarcinoma (PDAC) has one of the lowest cancer survival rates. Recent studies using RAS inhibitors have opened the door to mo...

doi.org/10.1073/pnas...

Interesting preclinical study. Will triple targeted therapy make a change in PDAC?

@pnas.org @cniostopcancer.bsky.social

Wenn die Union Lifestyle-Teilzeit verbietet, gibt Markus Söder dann sein Amt als Ministerpräsident auf?

The self sabotage of American science in full display.

Thousands of grants supporting clinical trials of new treatments, basic science and clinical translation have been terminated over the last 12 months.

www.nature.com/immersive/d4...

Spandidos Publications: International Journal of Oncology International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Great review on a very important and current topic: sex differences in medicine, in this case in pancreatic cancer. Outstanding collaboration within the Pancreas2000 program of @eurpancreaticclub.bsky.social @gio-marchegiani.bsky.social @maloehr.bsky.social
www.spandidos-publications.com/ijo/68/3/35

Blick rauf gibt's auch noch...😁

The phrase is missing a verb... Maybe "got" or "was awarded" ?😁

Blick in die Schlick und Blick zurück...
#splitboarding, #tirol

Something joyful that slipped a bit in the end of last year was that our resident / PostDoc Michael Günther the 2nd place CCCI young investigator award 2025! Congratulations 🎉
@i-med.ac.at

Single-cell integration and multi-modal profiling reveals phenotypes and spatial organization of neutrophils in colorectal cancer The immune composition of the tumor microenvironment has a major impact on the therapy response in patients with colorectal cancer. Here, we built an …

Congratulations to our (now) PostDoc Niloofar Nemati and thank you all for the chance to contribute to this great collaborative effort! @i-med.ac.at @cellpress.bsky.social
www.sciencedirect.com/science/arti...

Heute im Museumsquartier im wunderbaren Wien über diesen großartigen Flyer der Künstlergruppe monochrom.at gestolpert! Made my day!

Mit welchem Wein ich meine Gesundheit ruiniere geht in erster Linie meine Gäste und mich was an... 🤣

Hmm.. where's my pancreas?

Lovely Christmas present for all GI- people... Gastroenterologists, surgeons, oncologists and of course PATHOLOGISTS! Got this from a nice colleague at our Institutes secret Santa event. Love it!

The Trump administration is punishing the American Academy of Pediatrics.

I have enough thoughts about this for an entire feature length documentary but here are two minutes of them.

(Spoiler alert: you can’t fight bad politics by staying apolitical.)

Diagnostic approaches to cancer of unknown primary—the pathologist’s perspective - memo - Magazine of European Medical Oncology Cancer of unknown primary (CUP), a rare metastatic malignancy for which a primary site cannot be established after the diagnostic workup, has an unfavorable prognosis. Histopathological assessment, in...

link.springer.com/article/10.1...
@i-med.ac.at

Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: a biomarker analysis from the NEOLAP trial (AIO-PAK-0113) The prognostic and predictive role of growth differentiation factor-15 (GDF-15) in localized, non-metastatic pancreatic ductal adenocarcinoma (PDAC) h…

Great collaboration! Translational results from the NEOLAP study. www.sciencedirect.com/science/arti...
@i-med.ac.at

Auch machbar! 😃

Hilft nur eins: Wir müssen die Gruppe gewinnen. Dann geht's gegen Uruguay. Ist machbar... 🤣

Habe ähnliches erlebt. Bin/war primär in der Medizin/Science-bubble unterwegs. Da war auf X viel mehr los. Viele wichtige und interessante Beiträge und Diskussionen. Der Rest unerträglich. Leider haben auch viele Organisationen nicht gewechselt. Hier lese ich dann halt mehr Gesellschaft/Politik.

Finally out! Normothermic ex-vivo liver perfusion as a model to study colorectal liver metastasis. Huge collaborative effort of surgery, oncology and translational sciences. Grateful that we could contribute!
@i-med.ac.at
rdcu.be/eMLob

Was machen die Worte von Friedrich Merz zum „Stadtbild“ mit schwarzen Polizisten, muslimischen Soldatinnen und mit Professoren, deren Eltern als Gastarbeiter nach Deutschland kamen?

www.stern.de/kultur/fried...

/1

This sarcoma btw is very aggressive as illustrated by blood vessel infiltration depicted here

Isn't it simply beautiful? Colonic mucosa. PanCK.. AP detection kit.

Abbildung 1A aus der Studie in Nature. Zeigt eine Kaplan-Meier Kurve mit Gesamtüberleben (Overall Survival, OS) in Prozent über die Zeit. In Rot geimpfte Patienten, in blau umgeimpfte Patienten. Man sieht ein deutlich verbessertes Gesamtüberleben. Adjustierte HR = 0.51

Wow. COVID-19 mRNA Impfung verstärkt Krebstherapie!
Neue Studie zeigt: COVID-mRNA Impfung vor Immuntherapie verbessert Überleben bei Lungen- und Hautkrebs deutlich (HR 0,51), durch Aktivierung von Immunantworten gegen den Tumor. Von wegen "Turbo-Krebs" #ImpfenSchuetzt
www.nature.com/articles/s41...

My case of the week: biopsy thought to be taken from a bone lesion (femur). Instead it was intramuscular and affected the bone directly. Known lung Mets. Everything was negative besides TFE3! Pics: HE,PAS, Vimentin, TFE3. Prime example of alveolar soft part sarcoma (ASPS)!

In 1916 the BMJ published an article about the work done by James Shearer, an American physician working in the British Army as a sergeant (because he had no British qualification). He had described a "delineator" which was better than x rays for portraying gunshot wounds. This caused a sensation and a lot of interest — but on investigation the work was found to have been invented. The BMJ published a retraction, but Shearer was tried by court martial and sentenced to death by firing squad.

Next time an institution tells you how seriously it takes research misconduct, ask them if it's *this* seriously. www.bmj.com/content/297/...